{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T03:49:07Z","timestamp":1773200947467,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["DK103750"],"award-info":[{"award-number":["DK103750"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["T32HL007224"],"award-info":[{"award-number":["T32HL007224"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"name":"American Heart Association (US)","award":["16GRNT27660006"],"award-info":[{"award-number":["16GRNT27660006"]}]},{"name":"Liver Institute and Foundation for Education and Research","award":["LIFER"],"award-info":[{"award-number":["LIFER"]}]},{"name":"Boston University Clinical & Translational Science Institute","award":["1UL1TR001430"],"award-info":[{"award-number":["1UL1TR001430"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12967-018-1587-3","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T09:58:37Z","timestamp":1533117517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["MRI of atherosclerosis and fatty liver disease in cholesterol fed rabbits"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2203-5848","authenticated-orcid":false,"given":"Erik","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Bodde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Ellison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Killiany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus Michael","family":"Bachschmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,1]]},"reference":[{"key":"1587_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","volume":"140","author":"CD Williams","year":"2011","unstructured":"Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140:124\u201331.","journal-title":"Gastroenterology"},{"key":"1587_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.tem.2015.11.008","volume":"27","author":"GN Ioannou","year":"2016","unstructured":"Ioannou GN. The role of cholesterol in the pathogenesis of NASH. Trends Endocrinol Metab. 2016;27:84\u201395.","journal-title":"Trends Endocrinol Metab"},{"key":"1587_CR3","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nrgastro.2013.149","volume":"10","author":"A Wree","year":"2013","unstructured":"Wree A, Broderick L, Canbay A, Hoffman HM, Feldstein AE. From NAFLD to NASH to cirrhosis\u2014new insights into disease mechanisms. Nat Rev Gastroenterol Hepatol. 2013;10:627.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1587_CR4","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/hep.23719","volume":"52","author":"BA Neuschwander-Tetri","year":"2010","unstructured":"Neuschwander-Tetri BA. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology. 2010;52:774\u201388.","journal-title":"Hepatology"},{"key":"1587_CR5","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1126\/science.1204265","volume":"332","author":"JC Cohen","year":"2011","unstructured":"Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science. 2011;332:1519\u201323.","journal-title":"Science"},{"key":"1587_CR6","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1053\/j.gastro.2015.07.056","volume":"149","author":"LA Beste","year":"2015","unstructured":"Beste LA, Leipertz SL, Green PK, Dominitz JA, Ross D, Ioannou GN. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001\u20132013. Gastroenterology. 2015;149:1471\u20131482.e5.","journal-title":"Gastroenterology"},{"key":"1587_CR7","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","volume":"116","author":"CA Matteoni","year":"1999","unstructured":"Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413\u20139.","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"1587_CR8","first-page":"S5","volume":"40","author":"JM Clark","year":"2006","unstructured":"Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006;40(Suppl 1):S5\u201310.","journal-title":"J Clin Gastroenterol"},{"key":"1587_CR9","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/ATVBAHA.115.305324","volume":"35","author":"H Hasturk","year":"2015","unstructured":"Hasturk H, Abdallah R, Kantarci A, Nguyen D, Giordano N, Hamilton J, et al. Resolvin E1 (RvE1) attenuates atherosclerotic plaque formation in diet and inflammation-induced atherogenesis. Arterioscler Thromb Vasc Biol. 2015;35:1123\u201333.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1587_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11883-017-0696-4","volume":"19","author":"JA Hamilton","year":"2017","unstructured":"Hamilton JA, Hasturk H, Kantarci A, Serhan CN, Van Dyke T. Atherosclerosis, periodontal disease, and treatment with resolvins. Curr Atheroscler Rep. 2017;19:57.","journal-title":"Curr Atheroscler Rep"},{"key":"1587_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/hep.26510","volume":"59","author":"A Verrijken","year":"2014","unstructured":"Verrijken A, Francque S, Mertens I, Prawitt J, Caron S, Hubens G, et al. Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 2014;59:121\u20139.","journal-title":"Hepatology"},{"key":"1587_CR12","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/lt.24134","volume":"21","author":"JG Stine","year":"2015","unstructured":"Stine JG, Shah NL, Argo CK, Pelletier SJ, Caldwell SH, Northup PG. Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis. Liver Transpl. 2015;21:1016\u201321.","journal-title":"Liver Transpl"},{"key":"1587_CR13","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","volume":"390","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, MacFadyen JG, Thuren T, Everett BM, Libby P, Glynn RJ, et al. Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet. 2017;390:1833\u201342.","journal-title":"Lancet"},{"key":"1587_CR14","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1001\/jamaoncol.2017.4844","volume":"4","author":"FK Tabung","year":"2018","unstructured":"Tabung FK, Liu L, Wang W, Fung TT, Wu K, Smith-Warner SA, et al. Association of dietary inflammatory potential with colorectal cancer risk in men and women. JAMA Oncol. 2018;4:366\u201373.","journal-title":"JAMA Oncol"},{"key":"1587_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/hep.22941","volume":"50","author":"GN Ioannou","year":"2009","unstructured":"Ioannou GN, Morrow OB, Connole ML, Lee SP. Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population. Hepatology. 2009;50:175\u201384.","journal-title":"Hepatology"},{"key":"1587_CR16","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/hep.21655","volume":"45","author":"K Yamaguchi","year":"2007","unstructured":"Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology. 2007;45:1366\u201374.","journal-title":"Hepatology"},{"key":"1587_CR17","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.febslet.2010.01.046","volume":"584","author":"K Wouters","year":"2010","unstructured":"Wouters K, van Bilsen M, van Gorp PJ, Bieghs V. Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice. FEBS. 2010;584:1001\u20135.","journal-title":"FEBS"},{"key":"1587_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1146\/annurev-nutr-071812-161230","volume":"33","author":"E Scorletti","year":"2013","unstructured":"Scorletti E, Byrne CD. Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease. Annu Rev Nutr. 2013;33:231\u201348.","journal-title":"Annu Rev Nutr"},{"key":"1587_CR19","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1172\/JCI0216452","volume":"110","author":"I Tabas","year":"2002","unstructured":"Tabas I. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J Clin Invest. 2002;110:905\u201311.","journal-title":"J Clin Invest"},{"key":"1587_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.plipres.2012.11.002","volume":"52","author":"G Musso","year":"2013","unstructured":"Musso G, Gambino R, Cassader M. Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis. Prog Lipid Res. 2013;52:175\u201391.","journal-title":"Prog Lipid Res"},{"key":"1587_CR21","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.bbadis.2015.05.015","volume":"1852","author":"G Arguello","year":"2015","unstructured":"Arguello G, Balboa E, Arrese M, Zanlungo S. Recent insights on the role of cholesterol in non-alcoholic fatty liver disease. Biochim Biophys Acta. 2015;1852:1765\u201378.","journal-title":"Biochim Biophys Acta"},{"key":"1587_CR22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/obr.12159","volume":"15","author":"T Hendrikx","year":"2014","unstructured":"Hendrikx T, Walenbergh S, Hofker MH. Lysosomal cholesterol accumulation: driver on the road to inflammation during atherosclerosis and non-alcoholic steatohepatitis. Obesity. 2014;15:424\u201333.","journal-title":"Obesity"},{"key":"1587_CR23","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.cmet.2012.04.004","volume":"15","author":"H-K Min","year":"2012","unstructured":"Min H-K, Kapoor A, Fuchs M, Mirshahi F, Zhou H, Maher J, et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab. 2012;15:665\u201374.","journal-title":"Cell Metab"},{"key":"1587_CR24","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jhep.2008.12.016","volume":"50","author":"F Caballero","year":"2009","unstructured":"Caballero F, Fern\u00e1ndez A, De Lacy AM, Fern\u00e1ndez-Checa JC, Caballer\u00eda J, Garc\u00eda-Ruiz C. Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH. J Hepatol. 2009;50:789\u201396.","journal-title":"J Hepatol"},{"key":"1587_CR25","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/hep.21763","volume":"46","author":"P Puri","year":"2007","unstructured":"Puri P, Baillie RA, Wiest MM, Mirshahi F, Choudhury J, Cheung O, et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology. 2007;46:1081\u201390.","journal-title":"Hepatology"},{"key":"1587_CR26","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1053\/jhep.2003.50132","volume":"37","author":"G Musso","year":"2003","unstructured":"Musso G, Gambino R, De Michieli F, Cassader M, Rizzetto M, Durazzo M, et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology. 2003;37:909\u201316.","journal-title":"Hepatology"},{"key":"1587_CR27","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/00365520802588133","volume":"44","author":"K Yasutake","year":"2009","unstructured":"Yasutake K, Nakamuta M, Shima Y, Ohyama A, Masuda K, Haruta N, et al. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol. Scand J Gastroenterol. 2009;44:471\u20137.","journal-title":"Scand J Gastroenterol"},{"key":"1587_CR28","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1194\/jlr.M800460-JLR200","volume":"50","author":"A Phinikaridou","year":"2009","unstructured":"Phinikaridou A, Hallock KJ, Qiao Y, Hamilton JA. A robust rabbit model of human atherosclerosis and atherothrombosis. J Lipid Res. 2009;50:787\u201397.","journal-title":"J Lipid Res"},{"key":"1587_CR29","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1161\/CIRCIMAGING.109.918524","volume":"3","author":"A Phinikaridou","year":"2010","unstructured":"Phinikaridou A, Ruberg FL, Hallock KJ, Qiao Y, Hua N, Viereck JC, et al. In vivo detection of vulnerable atherosclerotic plaque by magnetic resonance imaging in a rabbit model. Circ Cardiovasc Imaging. 2010;3:323\u201332.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1587_CR30","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1161\/CIRCIMAGING.112.000176","volume":"6","author":"A Phinikaridou","year":"2013","unstructured":"Phinikaridou A, Hua N, Pham T, Hamilton JA. Regions of low endothelial shear stress colocalize with positive vascular remodeling and atherosclerotic plaque disruption: an in vivo magnetic resonance imaging study. Circ Cardiovasc Imaging. 2013;6:302\u201310.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1587_CR31","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1161\/01.CIR.91.3.776","volume":"91","author":"GS Abela","year":"1995","unstructured":"Abela GS, Picon PD, Friedl SE, Gebara OC, Miyamoto A, Federman M, et al. Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model. Circulation. 1995;91:776\u201384.","journal-title":"Circulation"},{"key":"1587_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.atherosclerosis.2015.11.013","volume":"244","author":"TA Pham","year":"2016","unstructured":"Pham TA, Hua N, Phinikaridou A, Killiany R, Hamilton J. Early in vivo discrimination of vulnerable atherosclerotic plaques that disrupt: a serial MRI study. Atherosclerosis. 2016;244:101\u20137.","journal-title":"Atherosclerosis"},{"key":"1587_CR33","doi-asserted-by":"publisher","first-page":"7392","DOI":"10.3748\/wjg.v20.i23.7392","volume":"20","author":"SS Lee","year":"2014","unstructured":"Lee SS, Park SH. Radiologic evaluation of nonalcoholic fatty liver disease. World J Gastroenterol. 2014;20:7392\u2013402.","journal-title":"World J Gastroenterol"},{"key":"1587_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1006\/jmre.1997.1244","volume":"129","author":"L Vanhamme","year":"1997","unstructured":"Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson. 1997;129:35\u201343.","journal-title":"J Magn Reson"},{"key":"1587_CR35","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1161\/ATVBAHA.107.141028","volume":"27","author":"Y Qiao","year":"2007","unstructured":"Qiao Y, Ronen I, Viereck J, Ruberg FL, Hamilton JA. Identification of atherosclerotic lipid deposits by diffusion-weighted imaging. Arterioscler Thromb Vasc Biol. 2007;27:1440\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1587_CR36","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1194\/jlr.M500431-JLR200","volume":"47","author":"FL Ruberg","year":"2006","unstructured":"Ruberg FL, Viereck J, Phinikaridou A, Qiao Y, Loscalzo J, Hamilton JA. Identification of cholesteryl esters in human carotid atherosclerosis by ex vivo image-guided proton MRS. J Lipid Res. 2006;47:310\u20137.","journal-title":"J Lipid Res"},{"key":"1587_CR37","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.cca.2006.05.001","volume":"369","author":"F Ritis De","year":"2006","unstructured":"De Ritis F, Coltorti M, Giusti G. An enzymic test for the diagnosis of viral hepatitis: the transaminase serum activities. 1957. Clin Chim Acta. 2006;369:148\u201352.","journal-title":"Clin Chim Acta"},{"key":"1587_CR38","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1111\/j.1572-0241.1999.01006.x","volume":"94","author":"D Sorbi","year":"1999","unstructured":"Sorbi D, Boynton J, Lindor KD. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol. 1999;94:1018\u201322.","journal-title":"Am J Gastroenterol"},{"key":"1587_CR39","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.jcmg.2010.09.004","volume":"3","author":"WS Kerwin","year":"2010","unstructured":"Kerwin WS. Noninvasive imaging of plaque inflammation. JACC Cardiovasc Imaging. 2010;3:1136\u20138.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1587_CR40","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/35018119","volume":"406","author":"H Okamoto","year":"2000","unstructured":"Okamoto H, Yonemori F, Wakitani K, Minowa T, Maeda K, Shinkai H. A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits. Nature. 2000;406:203\u20137.","journal-title":"Nature"},{"key":"1587_CR41","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1161\/01.ATV.0000054658.91146.64","volume":"23","author":"PJ Barter","year":"2003","unstructured":"Barter PJ, Brewer HB Jr, Chapman MJ, Hennekens CH, Rader DJ, Tall AR. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol. 2003;23:160\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1587_CR42","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.pharmthera.2014.09.009","volume":"146","author":"J Fan","year":"2015","unstructured":"Fan J, Kitajima S, Watanabe T, Xu J, Zhang J, Liu E, et al. Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine. Pharmacol Ther. 2015;146:104\u201319.","journal-title":"Pharmacol Ther"},{"key":"1587_CR43","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.2337\/dc14-1239","volume":"38","author":"J Bazick","year":"2015","unstructured":"Bazick J, Donithan M, Neuschwander-Tetri BA, Kleiner D, Brunt EM, Wilson L, et al. Clinical model for NASH and advanced fibrosis in adult patients with diabetes and NAFLD: guidelines for referral in NAFLD. Diabetes Care. 2015;38:1347\u201355.","journal-title":"Diabetes Care"},{"key":"1587_CR44","first-page":"276","volume":"3","author":"JC Melvin","year":"2012","unstructured":"Melvin JC, Rodrigues C, Holmberg L, Garmo H, Hammar N, Jungner I, et al. Gamma-glutamyl transferase and C-reactive protein as alternative markers of metabolic abnormalities and their associated comorbidities: a prospective cohort study. Int J Mol Epidemiol Genet. 2012;3:276\u201385.","journal-title":"Int J Mol Epidemiol Genet"},{"key":"1587_CR45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12986-016-0097-7","volume":"13","author":"SS Ali","year":"2016","unstructured":"Ali SS, Oni ET, Blaha MJ, Veledar E, Feiz HR, Feldman T, et al. Elevated gamma-glutamyl transferase is associated with subclinical inflammation independent of cardiometabolic risk factors in an asymptomatic population: a cross-sectional study. Nutr Metab. 2016;13:37.","journal-title":"Nutr Metab"},{"key":"1587_CR46","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.atherosclerosis.2014.01.010","volume":"233","author":"RD Bradley","year":"2014","unstructured":"Bradley RD, Fitzpatrick AL, Jacobs DR Jr, Lee D-H, Swords Jenny N, Herrington D. Associations between \u03b3-glutamyltransferase (GGT) and biomarkers of atherosclerosis: the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis. 2014;233:387\u201393.","journal-title":"Atherosclerosis"},{"key":"1587_CR47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/labinvest.3700030","volume":"84","author":"G Ramadori","year":"2004","unstructured":"Ramadori G, Saile B. Portal tract fibrogenesis in the liver. Lab Invest. 2004;84:153\u20139.","journal-title":"Lab Invest"},{"issue":"Spec Iss A","key":"1587_CR48","first-page":"3029","volume":"88","author":"E Goguet-Surmenian","year":"2009","unstructured":"Goguet-Surmenian E, Hasturk H, Kantarci A, Andry C, Serhan CN, Van Dyke TJ. Preclinical hepatotoxicity of lipid mediators in rabbits. J Dent Res. 2009;88(Spec Iss A):3029.","journal-title":"J Dent Res"},{"key":"1587_CR49","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11883-017-0692-8","volume":"19","author":"GE Sanda","year":"2017","unstructured":"Sanda GE, Belur AD, Teague HL, Mehta NN. Emerging associations between neutrophils, atherosclerosis, and psoriasis. Curr Atheroscler Rep. 2017;19:53.","journal-title":"Curr Atheroscler Rep"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1587-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-018-1587-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1587-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T14:38:08Z","timestamp":1568990288000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-018-1587-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1587"],"URL":"https:\/\/doi.org\/10.1186\/s12967-018-1587-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,1]]},"assertion":[{"value":"17 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"215"}}